68Ga-prostate-specific membrane antigen, a potential radiopharmaceutical in PET/CT to detect primary cholangiocarcinoma

dc.contributor.authorChahinian, Rita A.
dc.contributor.authorEl-Amine, Ahmad
dc.contributor.authorMatar, Sayed
dc.contributor.authorAnnan, Mostafa
dc.contributor.authorShamseddine, Ali I.
dc.contributor.authorHaidar, Mohamad B.
dc.contributor.departmentDiagnostic Radiology
dc.contributor.departmentPathology and Laboratory Medicine
dc.contributor.departmentInternal Medicine
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:41:10Z
dc.date.available2025-01-24T11:41:10Z
dc.date.issued2020
dc.description.abstract68Ga Prostate-specific membrane antigen (PSMA) is an increasingly popular radiopharmaceutical tracer in prostate cancer and is becoming increasingly researched in other cancers such as breast cancer, renal cell carcinoma, glioblastoma multiforme, among others. Cholangiocarcinoma is the second most common primary hepatic malignant tumor; it is an aggressive tumor with a 5-year survival rate of less than 5 %. We herein report a case of primary cholangiocarcinoma detected on 68Ga-PSMA PET-CT conducted as part of follow up for prostate cancer and confirmed by biopsy and immunohistochemistry. © 2020 mums.ac.ir All rights reserved.
dc.identifier.doihttps://doi.org/10.22038/AOJNMB.2020.46939.1314
dc.identifier.eid2-s2.0-85101331097
dc.identifier.urihttp://hdl.handle.net/10938/29685
dc.language.isoen
dc.publisherMashhad University of Medical Sciences
dc.relation.ispartofAsia Oceania Journal of Nuclear Medicine and Biology
dc.sourceScopus
dc.subjectCholangiocarcinoma
dc.subjectPet-ct
dc.subjectPsma
dc.title68Ga-prostate-specific membrane antigen, a potential radiopharmaceutical in PET/CT to detect primary cholangiocarcinoma
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2020-3441.pdf
Size:
1.13 MB
Format:
Adobe Portable Document Format